The Effect of Horizontal Whole-body Vibration Therapy in Post-menopausal Women
Osteoporosis, Whole Body Vibration
About this trial
This is an interventional treatment trial for Osteoporosis focused on measuring Osteoporosis, Whole-body vibration, Bone mineral density, Quality of life
Eligibility Criteria
Inclusion Criteria:
- Post-menopausal female patients
- Aged 45-65 years
- L2-L4 and/or femoral neck BMD T-scores of -2.5 to-3.
Exclusion Criteria:
- Osteoporotic fractures
- Metabolic bone disease
- Hyperparathyroidism
- Presence of hyperthyroidism
- History of steroids or current use of steroids
- History of bisphosphonate consumption over the previous year
- Women with lumbar disk herniation, spondylolisthesis or narrow spinal canal
- Conditions that constitute a contraindication for vibration therapy;
- Kidney stones
- Gallstones
- Pregnancy
- Epilepsy
- Cancer
- Pacemaker
- Treatment of orthostatic hypotension
- Recent implants (joint, cochlear, or corneal)
- Recent surgery
- Recent intrauterine device
- Acute thrombosis or hernia
- Acute rheumatoid arthritis
- Serious cardiovascular event
- Diabetes
- Migraine
Sites / Locations
- Feyza Akan BEGOGLU
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Other
Whole Body Vibration and Infrared Therapy Group
Infrared Therapy Group
Classical Treatment Group
Patients in the whole body vibration and infrared group received vibration therapy with a frequency of 60 Hz and amplitude of 0.5-2 mm and infrared therapy at a wavelength of 550-950 nm 20 minutes daily session, 2 days per weeks for 3 months.1000 mg Ca and 880 IU vitamin D treatment were given.
Patients in infrared therapy group received infrared therapy at a wavelength of 550-950 nm 20 minutes daily session, 2 days per weeks for 3 months.1000 mg Ca and 880 IU vitamin D treatment were given.
1000 mg Ca and 880 IU vitamin D treatment were given.